Medtronic $88 Million Hernia Mesh Verdict
On 5 August 2026, a federal jury in Boston delivered a verdict ordering Medtronic (NYSE:MDT) to pay $88 million to Larry Patterson and his wife, residents of Alabama, for injuries linked to a hernia‑repair mesh implant manufactured by Medtronic’s Covidien unit. The implant was placed in Patterson in 2017, and the jury concluded that Covidien failed to provide adequate warnings about the device’s risks. The award does not include punitive damages, and the jury found no evidence of fraud by Covidien.
Patterson’s attorney, Timothy O’Brien, highlighted that the $88 million judgment is the largest among more than a dozen hernia‑mesh and transvaginal‑mesh cases that have proceeded to trial. The trial lasted three weeks and represents the first resolution among thousands of pending lawsuits targeting Medtronic over its hernia‑mesh products.
Medtronic issued a statement affirming confidence in Covidien’s hernia‑mesh products, noting that they have been used safely and effectively in millions of patients over the past two decades and remain the standard of care for repairing all but the smallest hernia defects. The company announced it will contest the verdict through post‑trial motions and an appeal.
The article, generated with AI assistance and reviewed by an editor, cites Reuters as the source and includes the stock ticker MDT‑0.80% indicating a modest share price movement following the news.